Press Releases

Filter Releases
 
Press Releases
Date Title and Summary
Jan 13, 2014
ORANGEBURG, N.Y., Jan. 13, 2014 (GLOBE NEWSWIRE) -- An outbreak of "Nightmare Bacteria," also known as the "Super Bug," has raised new alarm bells in the healthcare industry over patient safety. The concern stems from 44 newly reported cases of cross-contamination infections as a result of endoscopic procedures done at Advocate Lutheran General Hos...
Jan 24, 2014
ORANGEBURG, N.Y., Jan. 24, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the third quarter of fiscal 2014, ended December 31, 2013...
Feb 3, 2014
ORANGEBURG, N.Y., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for the third quarter and first nine months of fiscal year 2014, ended December 31, 2013.Third Q...
Feb 10, 2014
ORANGEBURG, N.Y., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Superbugs. Nightmare Bacteria. Antibiotic Resistant Strains. No matter what you call it, it's bad news for hospitals, which face increasingly stringent financial penalties under the Affordable Care Act. Specifically, patient readmissions and follow-up diagnostics due to hospital-acquired infection...
Mar 4, 2014
Vision-Sciences' EndoSheath® Technology Provides Guaranteed Sterility ORANGEBURG, N.Y., March 4, 2014 (GLOBE NEWSWIRE) -- Patient Safety Awareness Week, March 2nd - 8th, is dedicated to heightening awareness to a variety of ways that patients can be more involved in their health care. Specifically highlighted is the issue of health care-ac...
Mar 13, 2014
ORANGEBURG, N.Y., March 13, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, announced today that Howard Zauberman, President and Chief Executive Officer, will participate in BTIG's Inaugural Snowbird Medi...
Mar 17, 2014
ORANGEBURG, N.Y., March 17, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, is pleased to announce that Cheryl Pegus, M.D., President of Caluent, Director and Strategic Advisor of Glytec, and the Lead Ind...
Apr 3, 2014
Vision-Sciences' EndoSheath® Technology Offers a Solution ORANGEBURG, N.Y., April 3, 2014 (GLOBE NEWSWIRE) -- A recent peer reviewed article published March 19, 2014 in The BMJ* by Steve Brozak and Anne Marie Noronha again establishes a case for an alternative to the conventional endoscope cleaning process and reviews why conventional clea...
Apr 21, 2014
ORANGEBURG, N.Y., April 21, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced that the Company will release its financial results for the fourth quarter and full year fiscal 2014, ended Marc...
Apr 28, 2014
ORANGEBURG, N.Y., April 28, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for the fourth quarter and full year fiscal 2014, ended March 31, 2014.Fourth Quarter Fiscal Y...
Page:
...
Next Last
 
= add release to Briefcase


View archived press releases from Vision-Sciences and Uroplasty